Moderna submitted its bivalent reminder to Health Canada for regulatory approval on June 30, with the goal of having it available this fall. The booster vaccine for people 12 years of age and older targets both the original strain of COVID-19 and the Omicron variant. The federal government has already purchased 12 million doses of the vaccine, with the supply expected this year. Pfizer-BioNTech has also submitted its bivalent enhancer for regulatory evaluation. This submission was made to Canada’s federal health regulator on July 25. “Our regulatory colleagues at Health Canada are working very quickly to review the submissions from Moderna and from Pfizer-BioNTech for the bivalent booster doses,” said Chief Public Health Officer Dr. Theresa Tam during an Aug. 22 press conference. “We have also secured an adequate supply of the bivalent formulation should regulatory authorities proceed with approval of the vaccines,” Tam said. Questions have been raised about whether Canadians should wait for bivalent doses to become available before rolling up their sleeves for an additional dose, which Tam said is a decision that should be made based on individual risk factors. After a technical briefing with Public Health Canada officials on Thursday, Health Minister Jean-Yves Duclos is scheduled to make an announcement about “the importance of vaccination against COVID-19 as we approach the fall.” With files from CTV News’ Mackenzie Gray and Kevin Gallagher
title: “Moderna S Omicron Specific Vaccine Will Be Approved Klmat” ShowToc: true date: “2022-11-23” author: “Joan Freas”
Moderna submitted its bivalent reminder to Health Canada for regulatory approval on June 30, with the goal of having it available this fall. The booster vaccine for people 12 years of age and older targets both the original strain of COVID-19 and the Omicron variant. The federal government has already purchased 12 million doses of the vaccine, with the supply expected this year. Pfizer-BioNTech has also submitted its bivalent enhancer for regulatory evaluation. This submission was made to Canada’s federal health regulator on July 25. “Our regulatory colleagues at Health Canada are working very quickly to review the submissions from Moderna and from Pfizer-BioNTech for the bivalent booster doses,” said Chief Public Health Officer Dr. Theresa Tam during an Aug. 22 press conference. “We have also secured an adequate supply of the bivalent formulation should regulatory authorities proceed with approval of the vaccines,” Tam said. Questions have been raised about whether Canadians should wait for bivalent doses to become available before rolling up their sleeves for an additional dose, which Tam said is a decision that should be made based on individual risk factors. After a technical briefing with Public Health Canada officials on Thursday, Health Minister Jean-Yves Duclos is scheduled to make an announcement about “the importance of vaccination against COVID-19 as we approach the fall.” With files from CTV News’ Mackenzie Gray and Kevin Gallagher
title: “Moderna S Omicron Specific Vaccine Will Be Approved Klmat” ShowToc: true date: “2022-11-19” author: “Anna Rooney”
Moderna submitted its bivalent reminder to Health Canada for regulatory approval on June 30, with the goal of having it available this fall. The booster vaccine for people 12 years of age and older targets both the original strain of COVID-19 and the Omicron variant. The federal government has already purchased 12 million doses of the vaccine, with the supply expected this year. Pfizer-BioNTech has also submitted its bivalent enhancer for regulatory evaluation. This submission was made to Canada’s federal health regulator on July 25. “Our regulatory colleagues at Health Canada are working very quickly to review the submissions from Moderna and from Pfizer-BioNTech for the bivalent booster doses,” said Chief Public Health Officer Dr. Theresa Tam during an Aug. 22 press conference. “We have also secured an adequate supply of the bivalent formulation should regulatory authorities proceed with approval of the vaccines,” Tam said. Questions have been raised about whether Canadians should wait for bivalent doses to become available before rolling up their sleeves for an additional dose, which Tam said is a decision that should be made based on individual risk factors. After a technical briefing with Public Health Canada officials on Thursday, Health Minister Jean-Yves Duclos is scheduled to make an announcement about “the importance of vaccination against COVID-19 as we approach the fall.” With files from CTV News’ Mackenzie Gray and Kevin Gallagher
title: “Moderna S Omicron Specific Vaccine Will Be Approved Klmat” ShowToc: true date: “2022-12-18” author: “Ryan Palmore”
Moderna submitted its bivalent reminder to Health Canada for regulatory approval on June 30, with the goal of having it available this fall. The booster vaccine for people 12 years of age and older targets both the original strain of COVID-19 and the Omicron variant. The federal government has already purchased 12 million doses of the vaccine, with the supply expected this year. Pfizer-BioNTech has also submitted its bivalent enhancer for regulatory evaluation. This submission was made to Canada’s federal health regulator on July 25. “Our regulatory colleagues at Health Canada are working very quickly to review the submissions from Moderna and from Pfizer-BioNTech for the bivalent booster doses,” said Chief Public Health Officer Dr. Theresa Tam during an Aug. 22 press conference. “We have also secured an adequate supply of the bivalent formulation should regulatory authorities proceed with approval of the vaccines,” Tam said. Questions have been raised about whether Canadians should wait for bivalent doses to become available before rolling up their sleeves for an additional dose, which Tam said is a decision that should be made based on individual risk factors. After a technical briefing with Public Health Canada officials on Thursday, Health Minister Jean-Yves Duclos is scheduled to make an announcement about “the importance of vaccination against COVID-19 as we approach the fall.” With files from CTV News’ Mackenzie Gray and Kevin Gallagher
